Mid-cap Picks with Anil Singhvi: Analyst Jay Thakkar picks Wockhardt, Alembic, Hindalco for bumper returns
In a conversation with Zee Business Managing Editor, Anil Singhvi, market expert Jay Thakkar has put his bets on the pharma sector. Thakkar picked Wockhardt Pharma as a top Buy with a long-term perspective
Mid-cap stocks are likely to have a good run in the markets and Zee Business has been indicating this to its viewers. While, it is not only informing viewers about the emerging market trends, the channel is also suggesting bets to earn bumper returns by investing in the right stocks in the mid-cap space. Zee Business experts are providing investment tips on mid-cap stocks with long-term, medium-term and short-term views.
In a conversation with Zee Business Managing Editor, Anil Singhvi, market expert Jay Thakkar has put his bets on the pharma sector. Thakkar picked Wockhardt Pharma as a top Buy with a long-term perspective. He puts the stop-loss at Rs 263 while the first target price is Rs 360 and second is Rs 380. The stock is currently trading at around Rs 287.
Anil Singhvi Speaks to Jay Thakkar: Watch Full Coverage Below
As for his positional pick, Thakkar picked up another stock from the pharma sector. He said that Alembic Pharma, for him, was a good bet. He puts the stop-loss at Rs 67. The stock is currently trading around Rs 77. The analyst said that he sees the first target price at Rs 95 and the second target price at Rs 102. He said that the stock has seen 4 waves of consolidation and if the fifth wave is achieved the stock should reach between Rs 67 to Rs 102.
See Zee Business Live TV Streaming Below:
Thakkar also picked Hindalco Industries with a short-term view.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.